Time and Location:
24 – 26 October 2023 | Barcelona, Spain
Meet us in Barcelona, engage with our speakers face to face about China GVP and relevant regulation changes, and get real-time feedback for your questions.
Pharmacovigilance regulations in China are constantly evolving and rapidly changing. With China becoming increasingly important for pharmaceutical companies, it is essential to remain updated on the latest regulatory developments to ensure compliance and safety.
As a leading global conference and exhibition on pharmacovigilance, Accestra is proud to sponsor and present about China GVP at the 9th Annual International Conference and Exhibition on Pharmacovigilance, Regulatory Affairs, Risk Management, and Clinical Trials.
2023 October 25, 16:00 – 16:30 PM (CET time), Fira Barcelona Gran Via, Spain
Navigating the Latest Regulations for Pharmacovigilance in China
- Overview of China PV framework
- Updates on China's GVP policies
- China's GVP requirements
- Best practices for compliance with China's GVP requirements and authority inspection key points
- Tips and pitfalls
Marylene Zhan, Senior PV Manager at Accestra Consulting
Ms. Marylene Zhan is a senior consultant at Accestra Consulting with extensive experience in pharmacovigilance and regulatory affairs. With a Master’s Degree from the Zhongnan University of Economics and Law. Marylene is a seasoned bilingual and bicultural consultant who specializes in China regulatory compliance and pharmacovigilance services (RA/PV). She has a wealth of knowledge on Chinese Pharmaceutical regulations and in-depth insight into dealing with Chinese market access requirements. Marylene has a rich experience in serving international pharma companies with market entry into China, providing support in the areas of adverse event monitoring and reporting, literature screening, PV agreements, Chinese GVP and local regulations, SOP & PSMF writing, and more.
See you there!
– Accestra Events Team